Production of highly thermally stable recombinant cholinesterases for the detection, detoxification and decontamination of organophosphorus compounds
Disclosed herein are methods for the large-scale production of a highly thermally stable acetylcholinesterase (AChE) and butyrylcholinesterase (BChE). Additionally, the expression methods disclosed herein can produce ChE preparations consisting of extract or purified forms that can be produced in high amounts and are highly thermally stable. These ChE products can be used in vitro detection, detoxification and decontamination methods.
1. A method for the large-scale production of a ChE protein in a plant extract, wherein said method comprises:
(a) expressing a ChE polypeptide in a plant cell, wherein said plant cell comprises a ChE encoding polynucleotide of SEQ ID NO:1, a PRAD encoding polynucleotide of SEQ ID NO:5, and a P19 encoding polynucleotide;
(b) generating a plant extract;
(c) adding chitosan to said plant extract;
(d) recovering said plant extract comprising said CheE polypeptide,
wherein said ChE polypeptide in said plant extract retains >70% enzymatic activity at 4° C. for at least 14 days and wherein ChE polypeptide is obtained at an amount >200 mg/kg of leaf biomass.
2. The method of claim 1 , wherein the ChE polypeptide in said plant extract retains >70% enzymatic activity at 25° C. for at least 14 days.
3. The method of claim 1 , wherein the ChE polypeptide in said plant extract retains >70% enzymatic activity at 37° C. for at least 14 days.
4. The method of claim 1 , wherein the ChE polypeptide in said plant extract retains >80% enzymatic activity at 40° C. for 8 hours.
5. The method of claim 1 , wherein the P19 encoding polynucleotide is polynucleotide sequence of SEQ ID NO:6.
6. The method of claim 1 , wherein the PRAD encoding polynucleotide is stably expressed.
7. The method of claim 6 , wherein the P19 encoding polynucleotide is stably expressed.
8. The method of claim 1 , wherein the encoded ChE and PRAD polypeptides are transiently expressed in the plant cell.
9. The method of claim 8 , wherein the P19 encoding polynucleotide is stably expressed.
10. The method of claim 1 , wherein the encoded ChE, PRAD, and P19 polypeptides are transiently expressed in the plant cell.
11. The method of claim 1 , wherein the ChE encoding polynucleotide and/or the PRAD encoding polynucleotide further comprises a polynucleotide encoding a targeting sequence.
12. The method of claim 11 , wherein the targeting sequence is a KDEL sequence.
13. The method of claim 11 , wherein the targeting sequence is at the C-terminus of the ChE and/or PRAD encoding polynucleotides.
14. The method of claim 1 , wherein the ChE encoding polynucleotide further comprises a polynucleotide encoding a Tag sequence.
15. The method of claim 1 , wherein the plant cell is a member of the Solanaceae family.
16. The method of claim 1 , wherein the plant cell is a tobacco plant.
17. The method of claim 1 , wherein the plant cell is a member of the Nicotiana genus.
18. The method of claim 17 , wherein the plant cell is Nicotiana benthamiana or Nicotiana tabacum.
19. The method of claim 1 , wherein the ChE encoding polynucleotide and/or the PRAD encoding polynucleotide and/or the P19 encoding polynucleotide is codon optimized for expression in plants.
20. The method of claim 19 , wherein the ChE, PRAD, and/or the P19 encoding polynucleotides are codon optimized for expression in tobacco plants.
21. The method of claim 1 , wherein the ChE, PRAD, or P19 encoding polynucleotides are contained in three separate vectors.
22. The method of claim 1 , wherein the ChE, PRAD, or P19 encoding polynucleotides are contained in two separate vectors.
23. The method of claim 1 , wherein the ChE, PRAD, and P19 encoding polynucleotides are contained in one vector.
24. The method of claim 1 , wherein said method further comprises the addition of collagen to said step (c).
25. The method of claim 1 , wherein said method further comprises purifying said ChE polypeptide from said plant extract.
26. The method of claim 24 , wherein said ChE polypeptide is purified using a column.
27. The method of claim 26 , wherein said column is a procainamide sepharose affinity chromatography column.
28. The method of claim 27 , wherein said ChE polypeptide is eluted from said column with a buffer containing procainamide, decamethonium or acetylcholine, chlorine chloride, tetra methyl ammonium bromide or a salt gradient.
29. The plant extract comprising the ChE polypeptide produced by the method of claim 1 .
30. The plant extract comprising the ChE polypeptide produced by the method of claim 2 .
31. The plant extract comprising the ChE polypeptide produced by the method of claim 3 .
32. The plant extract comprising the ChE polypeptide produced by the method of claim 4 .
33. The plant extract comprising the ChE polypeptide produced by the method of claim 1 , wherein said ChE polypeptide is stable:
a. at least 20-22° C. for at least 24 hours;
b. at least 70° C. as a lyophilized form for at least 2 weeks;
c. at least 70° C. as a lyophilized form for at least 3 weeks;
d. at least 70° C. as a lyophilized form for at least 4 weeks;
e. at least 70° C. as a lyophilized form for at least 5 weeks;
f. at least 70° C. as a lyophilized form for at least 6 weeks; and
g. capable of detecting OP on surfaces at extreme temperatures (such as at 50° C. and/or 0° C.).
34. The plant extract comprising the ChE polypeptide of claim 29 , wherein said plant extract is a powder, liquid, or freeze-dried formulation.
35. A plant cell used in the method of claim 1 .
36. The plant cell of claim 35 , wherein the plant cell is a member of the Solanaceae family.
37. The plant cell of claim 35 , wherein the plant cell is a tobacco plant.
38. The plant cell of claim 35 , wherein the plant cell is a member of the Nicotiana genus.
39. The plant cell of claim 38 , wherein the plant cell is Nicotiana benthamiana or Nicotiana tabacum.
40. A method of detection, detoxification and/or decontamination of an organophosphorus compound comprising: applying the plant extract comprising said ChE polypeptide of claim 1 to a surface to detect, detoxify and/or decontaminate an organophosphorus compound.
41. The method of claim 40 , wherein the detection, detoxification and/or decontamination occurs on a solid surface.
42. The method of claim 41 , wherein the solid surface is at or above physiological temperature.
43. The method of claim 42 , wherein the solid surface is at temperatures above 80° F.
44. The method of claim 41 , wherein the solid surface is below physiological temperature.
45. The method of claim 40 , wherein the surface comprises a liquid droplet.
46. The method of claim 40 , wherein the surface is an exposed dry surface.